公司资料
Endra 股价、新闻与催化剂
- 股票代码:
- NDRA
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
4.49 USD (+0.45%)
收盘价
最后更新: 2026年8月17日
9.32M USD
市值
股价为何变动
As of Aug 17, 2026, NDRA closed up 0.45% at $4.49. No new same-company headline was identified in the current news window.
公司概览
业务概览
Endra was a medical technology company focused on thermo-acoustic imaging and diagnostic applications. Its business was aimed at noninvasive imaging rather than therapeutics.
所在地与行业分类
Endra was headquartered in the United States and listed on NASDAQ. It sat in medical devices and imaging technology rather than biotechnology.
商业模式特征
The company depended on product validation, adoption, and the ability to prove its imaging platform had a practical market. Investors watched clearances, commercialization, and capital efficiency.
生物医药行业定位
Endra belongs in the imaging-device layer of healthcare. It is not biotech, but it is part of the broader diagnostics infrastructure where noninvasive technology matters.
未来催化剂
- Endra’s catalysts are Thermo-Acoustic Enhanced Ultrasound platform updates and any commercialization step that shows the company can still gain traction. The market will care about whether the technology can become practical.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。